Contract · Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program
DEPT OF DEFENSE / DEFENSE HEALTH AGENCY (DHA) San Antonio, TX
- Status Closes in 4 days
- Amount Amount not listed
- Set-aside No Set aside used
Scope
The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents.
The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF).
Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry.
The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision.
This process is described in the attached RFQ.
P&T COMMITTEE MEETING: The following November 2026 newly approved drugs will be reviewed: a.
Adquey - Atopic - Subclass: Topical Agents b.
Armlupeg - White Blood Cell Stimulants - Subclass: Pegfilgrastims c.
Beqalzi - Oncological Agents - Non-BTKI for Chronic Lymphocytic Leukemia-Small Lymphocytic Lymphoma d.
Bixlenvo - Antiretrovirals - Subclass: Combinations e.
Clotic - Antifungals - Subclass: NA f.
Etcamah - Breast Cancer Agents - Estrogen Receptor Antagonist g.
Langlara - Insulins - Subclass: Basal h.
Lisraya - Targeted Immunomodulatory Biologics – NA i.
Mimrylo - Hematological Agents – NA j.
Nuzolvence...
Typical award value
No award history yet for this category (NAICS 325412).
Timeline
-
Posted
Oct 8, 2026
-
Listing updated
Oct 20, 2026
-
Status
Closing soon
How to bid on this
This is a contract solicitation, not a grant. To bid, you submit a proposal (usually a price and a description of how you would do the work) directly to the government, through the channel the official listing specifies, not through Oppward.
- Make sure your business has an active SAM.gov registration. You cannot be paid on a federal contract without one.
- Read the full solicitation on the official listing above, especially the scope of work, not just this summary. Our guide to reading a solicitation walks through what to look for.
- Check the set-aside listed above and confirm your business actually qualifies for it before you spend time on a proposal. See our guide to set-asides if the category is unfamiliar.
- Submit your proposal by the deadline, using the exact submission method the official listing states. A technically on-time bid sent the wrong way is often treated as late.
Get contracts like this one matched to your business, free.